Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors
Future Medicinal Chemistry · 2024
DOI: 10.4155/fmc-2023-0336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2024. Verfasst von Mona S El-Zoghbi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Menoufia University, Egypt. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University Project Fund, Princess Nourah bint Abdulrahman University Researchers.
Abstract (Originalsprache)
Aim
The purpose of this work is to create and synthesize a new class of chemicals: 3-cyano-2-substituted pyridine compounds with expected multitarget inhibition of histone deacetylase (HDAC) and tubulin. Materials & methods: The target compounds (3a-c, 4a-c and 5a-c) were synthesized utilizing 6-(4-methoxyphenyl)-2-oxo-4-(3,4,5-trimethoxyphenyl)-3-cyanopyridine, with various linkers and zinc-binding groups (ZBGs).
Results
Most of the tested compounds showed promising growth inhibition, and hydroxamic acid-containing hybrids possessed higher HDAC inhibition than other ZBGs. Compound 4b possessed the highest potency; however, it showed the most tubulin polymerization inhibition. Docking studies displayed good binding into HDAC1 and six pockets and tubulin polymerization protein.
Conclusion
Compound 4b could be considered a good antitumor candidate to go further into in vivo and clinical studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Menoufia University, Egypt.
- Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Minia, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag, 82524, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Menoufia University, Menoufia, Egypt.
- Department of Chemistry, College of Science, Princess Nourah Bint Abdulrahman University, PO Box 84428, Riyadh, 11671, Saudi Arabia.
ORCID-Profile: Mona S El-Zoghbi, Amr Ka Bass, Gamal El-Din A Abuo-Rahma, Mamdouh Fa Mohamed, Mohamed Badr, Hanan A Al-Ghulikah, El-Shimaa Mn Abdelhafez
Förderung
- Princess Nourah bint Abdulrahman University Project Fund
- Princess Nourah bint Abdulrahman University Researchers
Zitieren
APA
El-Zoghbi, M. S., Bass, A. K., A Abuo-Rahma, G. E., Mohamed, M. F., Badr, M., Al-Ghulikah, H. A., & Abdelhafez, E. M. (2024). Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors. Future Medicinal Chemistry. https://doi.org/10.4155/fmc-2023-0336
Vancouver
El-Zoghbi MS, Bass AK, A Abuo-Rahma GE, Mohamed MF, Badr M, Al-Ghulikah HA, et al. Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors. Future Medicinal Chemistry. 2024. doi:10.4155/fmc-2023-0336
BibTeX
@article{ElZoghbi2024,
author = {El-Zoghbi, Mona S and Bass, Amr Ka and A Abuo-Rahma, Gamal El-Din and Mohamed, Mamdouh Fa and Badr, Mohamed and Al-Ghulikah, Hanan A and Abdelhafez, El-Shimaa Mn},
title = {Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors},
journal = {Future Medicinal Chemistry},
year = {2024},
doi = {10.4155/fmc-2023-0336}
}
EUVIMED